Clinical Trial Update: A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa [Phase 3]

View source ↗

Summary

This is a Phase 3 study to assess pharmacokinetics and safety of Bimekizumab in children and adolescents with moderate to severe hidradenitis suppurativa. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Hidradenitis Suppurativa | Phase 3 | Status: RECRUITING